NEWS
Accuray in the Media
The most recent news articles and media coverage of Accuray, our treatment delivery systems and software, and our partners around the world.
-
Accuray to Report Fiscal 2019 Third Quarter Financial Results on April 23, 2019
SUNNYVALE, Calif. , April 2, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its third quarter ended March 31, 2019 on Tuesday, April 23, 2019 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m. […]
-
Phase 3 Randomized Trial Data Shows SBRT has Similar Acute Safety Profile to Conventional Radiation Therapy in Patients with Localized Prostate Cancer
Data Presented at the 2019 Genitourinary Cancers Symposium Reinforces Benefits of Short Course of Treatment Using Stereotactic Body Radiation Therapy for Low- or Intermediate-Risk Prostate Cancer SUNNYVALE, Calif. , Feb. 22, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced […]
-
Accuray And China Isotope And Radiation Corporation Enter Joint Venture Contract To Manufacture And Sell Radiation Oncology Systems In China
Joint Venture Uniquely Positioned to Serve World's Largest Growth Market for Radiation Oncology Systems Conference Call Today at 6:00 a.m. PT/ 9:00 a.m. ET SUNNYVALE, Calif. and TIANJIN, China , Jan. 28, 2019 /PRNewswire/ -- Accuray Asia Limited , a subsidiary of Accuray Incorporated […]
-
Accuray Reports Fiscal 2019 Second Quarter Results
SUNNYVALE, Calif. , Jan. 22, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the second quarter of fiscal 2019 ended December 31, 2018 . Fiscal Second Quarter Highlights Gross orders increased 29 percent year over year to a record $100.2 […]
-
The Urology Group Surpasses 1,600 Prostate Cancer Patients Treated with the Accuray CyberKnife® M6™ System
SUNNYVALE, Calif. , Jan. 17, 2019 /PRNewswire/ -- According to the American Cancer Society , prostate cancer is the most common cancer in American men other than skin cancer. Accuray Incorporated (NASDAQ: ARAY) and The Urology Group (TUG) are partnering to recognize TUG's commitment to […]
